chr2-120990246-G-A
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_001374353.1(GLI2):c.4281G>A(p.Met1427Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00384 in 1,613,706 control chromosomes in the GnomAD database, including 89 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Consequence
NM_001374353.1 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -20 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
GLI2 | NM_001374353.1 | c.4281G>A | p.Met1427Ile | missense_variant | 14/14 | ENST00000361492.9 | NP_001361282.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
GLI2 | ENST00000361492.9 | c.4281G>A | p.Met1427Ile | missense_variant | 14/14 | 1 | NM_001374353.1 | ENSP00000354586.5 |
Frequencies
GnomAD3 genomes AF: 0.00472 AC: 719AN: 152200Hom.: 10 Cov.: 33
GnomAD3 exomes AF: 0.00970 AC: 2435AN: 251078Hom.: 59 AF XY: 0.00775 AC XY: 1053AN XY: 135804
GnomAD4 exome AF: 0.00375 AC: 5478AN: 1461388Hom.: 79 Cov.: 34 AF XY: 0.00355 AC XY: 2583AN XY: 727020
GnomAD4 genome AF: 0.00473 AC: 720AN: 152318Hom.: 10 Cov.: 33 AF XY: 0.00481 AC XY: 358AN XY: 74474
ClinVar
Submissions by phenotype
not provided Benign:5
Benign, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Jan 01, 2024 | GLI2: BP4, BS1, BS2 - |
Benign, criteria provided, single submitter | clinical testing | Center for Pediatric Genomic Medicine, Children's Mercy Hospital and Clinics | Oct 13, 2016 | - - |
Likely benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Benign, criteria provided, single submitter | clinical testing | GeneDx | Nov 06, 2018 | This variant is associated with the following publications: (PMID: 27535533, 17096318, 22967285) - |
Benign, criteria provided, single submitter | clinical testing | ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories | Nov 29, 2023 | - - |
Holoprosencephaly 9;C4014479:Postaxial polydactyly-anterior pituitary anomalies-facial dysmorphism syndrome Benign:2
Benign, criteria provided, single submitter | clinical testing | Fulgent Genetics, Fulgent Genetics | Dec 09, 2021 | - - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Dec 31, 2019 | - - |
Holoprosencephaly 9 Benign:2
Likely benign, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Apr 27, 2017 | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). Publications were found based on this search. The evidence from the literature, in combination with allele frequency data from public databases where available, was sufficient to determine this variant is unlikely to cause disease. Therefore, this variant is classified as likely benign. - |
Benign, criteria provided, single submitter | research | Broad Center for Mendelian Genomics, Broad Institute of MIT and Harvard | - | The heterozygous p.Met1444Ile variant, sometimes called p.Met1116Ile due to a difference in cDNA numbering, in GLI2 has been identified in an individual with possible holoprosencephaly and 4 individuals with combined pituitary hormone deficiency but not holoprosencephaly (PMID: 17096318, 22967285). This variant has also been identified in >6% of Latino chromosomes and 20 homozygotes by ExAC (http://gnomad.broadinstitute.org/). In summary, this variant meets criteria to be classified as benign for autosomal dominant holoprosencephaly with heminasal aplasia and orbital anomalies. - |
not specified Benign:1
Benign, criteria provided, single submitter | clinical testing | Eurofins Ntd Llc (ga) | Jul 10, 2014 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at